lamivudine has been researched along with Acquired Immune Deficiency Syndrome in 216 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 97 (44.91) | 18.2507 |
| 2000's | 84 (38.89) | 29.6817 |
| 2010's | 25 (11.57) | 24.3611 |
| 2020's | 10 (4.63) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Dumond, JB; Fiscus, SA; Horton, AL; Kashuba, AD; Patterson, KB; Rezk, NL; Tappouni, HL; Tien, HC; Vourvahis, M; Yeh, RF | 1 |
| Adkison, KK; Baker, M; Brothers, C; Buchanan, AM; Davies, M; Parasrampuria, R; Sewell, N; Singh, RP; Wolstenholme, A | 1 |
| Arribas, JR; Bamford, A; Beguelin, C; Behrens, GMN; Boesecke, C; Cinque, P; Collins, S; Cotter, AG; De Miguel, R; Guaraldi, G; Kirk, O; Kowalska, JD; Mallon, PWG; Marzolini, C; Molina, JM; Podlekareva, D; Rauch, A; Ryom, L; Waalewijn, H; Welch, S; Winston, A | 1 |
| Adebisi, SA; Adedeji, NO; Adedeji, TA; Ajeigbe, AK; Ajose, AO; Akande, AA; Fawale, MB; Jeje, OA; Okesina, BA; Smith, OS | 1 |
| Airewele, G; Bulsara, S; Despotovic, J; Elyanu, P; Grimes, A; Haq, H; Kekitiinwa, A; Kim, TO; Lubega, J; Lumumba, M; Matshaba, M; Musoke, P; Peckham, E; Scheurer, M; Wanless, SR | 1 |
| Andreoni, M; Barchi, V; De Simone, G; Iannazzo, R; Iannetta, M; Massa, B; Rindi, LV; Sarmati, L | 1 |
| Alagaratnam, J; Ambrosioni, J; Bamford, A; Boesecke, C; Calmy, A; Cinque, P; Guaraldi, G; Koval, A; Levi, L; Martínez, E; Marzolini, C; Mastrangelo, A; Mendao, L; Molina, JM; Oprea, C; Rockstroh, JK; Van Bremen, K; Waalewijn, H; Welch, S; Winston, A | 1 |
| Cheng, J; He, S; He, Y; Liu, H; Lu, C; Yang, T; Yao, Y; Yin, K; Zhou, R | 1 |
| Amaro, C; Azurara, L; Miroux-Catarino, A; Monteiro, AF; Silva, L; Viana, I | 1 |
| Li, A; Li, C; Li, H; Li, W; Li, X; Xia, W | 1 |
| Basu, A; Biswas, A; Das, BK; Nischal, N; Soneja, M; Sood, R; Wig, N | 1 |
| Akunuri, S; Kallampallil, J; Leong, S; Maweni, R | 1 |
| Amariles, P; Castañeda, C; Galindo, J; Mueses-Marín, HF | 1 |
| Alobwede, SM; Kongnyuy, EJ; Shey, MS; Wiysonge, CS | 1 |
| Borok, MZ; Campbell, TB; Makadzange, AT; Mhlanga, TO; Nelson, BC | 1 |
| Cortes, CP; Otto-Knapp, R; Saavedra, F; Weitzel, T; Wolff, M | 1 |
| Clifford, DB; Haas, DW; Johnson, DH; Leger, PD; Li, J; McLaren, PJ; Robbins, GK; Shafer, RW | 1 |
| Aghokeng, AF; Chia, JE; Delaporte, E; Einterz, E; Eymard-Duvernay, S; Molina, JM; Mpoudi-Ngole, E; Peeters, M; Taieb, F | 1 |
| Holla, P; Jameel, S; Munshi, SU; Panda, H; Rewari, BB | 1 |
| Fujita, J; Haranaga, S; Higa, F; Nakamura, K; Tamayose, M; Tasato, D; Tateyama, M; Yara, S | 1 |
| Fan, P; Li, J; Li, N; Liang, Y; Ma, Y; Sun, D; Wang, Z; Yang, W; Zhu, Q | 1 |
| Amed, AM; Araujo Júnior, E; Júnior, LK; Nakamura, MU; Simões, J; Vangelotti, AM | 1 |
| Andrews, M; Condoluci, DV; Luber, AD | 1 |
| Lang, L | 1 |
| Abbasi, NR; Wang, N | 1 |
| Iseniyi, JO; Odeigah, L; Olatunji, PO; Olawumi, HO; Salami, AK | 1 |
| Black, V; Guidozzi, F | 1 |
| Ag Aboubacrine, S; Coulibaly, S; Coulibaly, SM; Harama, M; Koumare, BY; Mariko, E; Oumar, AA; Traoré, HA | 1 |
| Dieng, AB; Diop, BM; Diop, SA; Diouf, A; Fall, MB; Lakh, A; Ndiaye, I; Niang, Kh; Seydi, M; Soumaré, M; Sow, A; Sow, PS; Tekpa, G | 1 |
| Christie, CD; Evans-Gilbert, T; Moore, J; Palmer, P; Pierre, RB; Rodriguez, B; Steel-Duncan, J; White, YR | 1 |
| Kongnyuy, EJ; Shang, J; Shey, M; Wiysonge, CS | 1 |
| Fujimoto, H; Fukutake, K; Funato, K; Hashimoto, Y; Yotsumoto, M | 1 |
| Lu, K; Mehrotra, DV | 1 |
| Dhlomo, S; Emery, S; Grandits, G; Khabo, P; Khanyile, T; Komati, S; Magongoa, D; Naidoo, LC; Neaton, JD; Polis, M; Qolohle, D; Ratsela, A | 1 |
| Ekwunife, OI; Iwuamadi, UI; Udeogaranya, OP; Ukwe, CV | 1 |
| Honda, M; Ishisaka, M; Ishizuka, N; Kimura, S; Oka, S | 1 |
| Donnelly, J | 1 |
| Dou, Z; Durako, S; Jiao, JH; Ma, Y; Xu, J; Yu, L; Zhang, F; Zhao, Y | 1 |
| Arasteh, K; Boven, K; Crauwels, H; De Wet, J; Gathe, J; Gold, J; Hodder, S; Kumar, P; Mohapi, L; Short, W; Vanveggel, S | 1 |
| Domingo, P; Gutierrez, Mdel M; Mateo, MG; Vidal, F | 1 |
| Bloom, A; Brown, TT; Daar, ES; Fedarko, N; Ha, B; Jahed, NC; Kitch, D; McComsey, GA; Melbourne, K; Sax, PE; Tierney, C | 1 |
| Bualert, L; Charungkiattikul, W; El Baidouri, F; Khositnithikul, R; Leelayoova, S; Mungthin, M; Naaglor, T; Ravel, C; Siripattanapipong, S; Thongsuksai, P | 1 |
| Carda-Broch, S; Casas-Breva, I; Esteve-Romero, J; Peris-Vicente, J; Rambla-Alegre, M | 1 |
| Capeau, J; Danner, SA; Domingo, P; Feeney, ER; Mallon, PW; Reiss, P; van Agtmael, MA; van Vonderen, MG; Villarroya, F; Wit, F | 1 |
| Gupta, U; Kumar, S; Nagpal, M; Tayal, V | 1 |
| Fox, L; Friedland, GH; Havlir, D; Pollard, RB; Richman, D; Smeaton, L; Tebas, P; Tierney, C | 1 |
| Anunnatsiri, S; Boonyaprawit, P; Chetchotisakd, P; Mootsikapun, P; Wankun, J | 1 |
| Jiménez, FJ; Labarga, P; Pinilla, J; Repiso, M | 1 |
| Blanche, S; Bodemer, C; Brousse, N; Fardet, L; Fraitag, S | 1 |
| Bakowska, E; Burkacka, E; Horban, A; Przybylska-Stengiel, KJ; Stanczak, GP; Stanczak, JJ; Tobolewska, EJ | 1 |
| Ait-Khaled, M; Babiker, AG; Compagnucci, A; De Rossi, A; Dunn, DT; Gibb, DM; Kaye, S; Loveday, C; Muñoz-Fernandez, MA; Pillay, D; Walker, AS | 1 |
| Bodasing, N; Fox, R; Gourlay, Y; Peters, SE; Seaton, RA | 1 |
| Anderson, KS; Feng, JY; Furman, PA; Jeffrey, JL; Qi, CC | 1 |
| Moyle, GJ | 2 |
| Clarke, B | 1 |
| Katano, H; Kimura, S; Niino, H; Oka, S; Teruya, K; Yamamoto, Y; Yasuoka, A | 1 |
| Nelson, K | 1 |
| Benhamou, Y; Poynard, T | 1 |
| Conway, B | 1 |
| Dussaix, E; Férey, MP; Fki, L; Mackiewicz, V; Roque-Afonso, AM | 1 |
| Bosch, RJ; Demeter, LM; Dykes, C; Furtado, M; Hammer, SM; Hart, S; Najjar, J; Wantman, M | 1 |
| Mauss, S | 1 |
| Fleck, F | 2 |
| Cohen, J | 3 |
| Back, DJ; Beijnen, JH; Crommentuyn, KM; Hoggard, PG; Huitema, AD; Kewn, S; Lange, JM; Prins, JM; Sankatsing, SU; Sparidans, RW | 1 |
| Demeter, LM; Erice, A; Eshleman, SH; Fischl, MA; Hammer, SM; Hellmann, NS; Ribaudo, HJ | 1 |
| Helen, L; Kanoksri, S; Siwaporn, C; Subsai, K | 1 |
| Cauda, R; Cingolani, A; De Luca, A; Di Giambenedetto, S; Marzocchetti, A; Pompucci, A; Scoppettuolo, G; Tumbarello, M; Vago, G | 1 |
| Christie, CD; Evans-Gilbert, T; Pierre, R; Rodriquez, B; Steel-Duncan, JC | 1 |
| Bower, M; Davies, E; Gazzard, B; Latham, V; Mandalia, S; Michailidis, C; Nelson, M; Stebbing, J | 1 |
| Lewis, W | 1 |
| Mahomed, FA; Rutherford, GW; Siegfried, NL; Van Deventer, PJ | 1 |
| Asiimwe, F; Behumbiize, P; Brooks, JT; Forna, F; Liechty, CA; Mermin, J; Solberg, P; Tong, T; Weidle, PJ; Were, W | 1 |
| Keiser, P; Nassar, N | 1 |
| Brown, JD; Kangwanprasert, M; Melish, J; Tice, A | 1 |
| Bridges, AS; Cohen, MS; Dumond, JB; Fiscus, SA; Kashuba, AD; Reddy, YS; Rodriguez, JF; Troiani, L; Yuen, GJ | 1 |
| Tastemain, C | 1 |
| Mitsuya, H | 1 |
| Beardsley, T | 2 |
| Cameron, J; Cammack, N; Cooley, TP; Gu, Z; Hirst, HM; McCaffrey, R; Montaner, JS; Ruedy, J; Salomon, H; Wainberg, MA | 1 |
| Cooley, TP; Hirst, HM; Montaner, JS; Pluda, JM; Quinn, JB; Reinhalter, NE; Ruedy, J; Shay, LE; Vicary, CA; Warthan, SN | 1 |
| Cupler, EJ; Dalakas, MC | 1 |
| Fong, IW | 1 |
| Dionne, G; Gao, Q; Gu, Z; Hiscott, J; Wainberg, MA | 1 |
| Arts, EJ; Boulerice, F; Geleziunas, R; Goldman, H; Wainberg, MA | 1 |
| Bartlett, JA; Heald, AE; Hsyu, PH; Mydlow, P; Robinson, P; Yuen, GJ | 1 |
| Boucher, CA; De Boer, RJ | 1 |
| Macready, N | 1 |
| Hirschel, B; Rutschmann, O | 1 |
| Heins, JR | 1 |
| Costes, O; Lafeuillade, A; Poggi, C; Profizi, N; Tamalet, C; Tourres, C | 1 |
| Craib, K; Gataric, N; Hogg, RS; Montaner, JS; O'Shaughnessy, MV; Schechter, MT; Yip, B | 1 |
| Jacobson, MA; O'Donnell, JJ; Owens, S; Pavan, PR; Pollard, R; Rao, N; Sattler, F; Zegans, M | 1 |
| Collins, DO; Sakamoto, A | 1 |
| Chenoweth, CE; Gobetti, JP | 1 |
| Balfour, HH; Chodakewitz, JA; Currier, JS; Demeter, LM; Deyton, LR; Eron, JJ; Feinberg, JE; Fischl, MA; Grimes, JM; Hammer, SM; Hughes, MD; Squires, KE | 1 |
| Mendila, M; Schmidt, RE; Stoll, M; Walter, GF | 1 |
| Gómez-Cano, M; Holguín, A; Mas, A; Soriano, V; Villalba, N | 1 |
| Cottalorda, J; Lefbvre, JC; Mariani, R; Monpoux, F; Sirvent, N | 1 |
| Baba, M; Makino, M; Piras, G | 1 |
| Beuers, U; Mühlhöfer, A; Samtleben, W; Thoenes, GH; von Appen, K; Weiss, M | 1 |
| DeMasi, R; Hill, AM; Montaner, JS | 1 |
| Boswell, SL | 1 |
| Bresson-Hadni, S; Dupond, JL; Gil, H; Rozenbaum, A; Vuitton, DA | 1 |
| Antinori, A; De Luca, A; Ortona, L | 1 |
| Cammack, N; Dalgleish, AG; Sharland, M; Watkins, AM; Westby, M | 1 |
| Addo, M; Altfeld, M; Kupfer, B; Pult, I; Rockstroh, JK; Spengler, U; Will, H | 1 |
| Cutrell, A; Harrer, T; Harrigan, RP; Katlama, C; Lanier, RE; Massip, P; Pearce, G; Staszewski, S; Steel, H; Tortell, SM; Yeni, P | 1 |
| Gilquin, J; Jubault, V; Kazatchkine, MD; Sert, C; Viard, JP | 1 |
| Al-Shboul, Q; Day, RD; Fan, Z; Huang, XL; Liebmann, JM; McMahon, DK; Mellors, JW; Riddler, SA; Rinaldo, CR | 1 |
| Binley, JM; Cao, Y; Chaudhry, MR; Frankel, S; Heath-Chiozzi, M; Ho, DD; Hurley, A; J, X; Jin, X; Leonard, JM; Markowitz, M; Moore, JP; Nixon, DF; Racz, P; Talal, A; Tenner-Racz, K; Vesanen, M; Yaman, M | 1 |
| Bontempo, FA; Dodson, SF; Fung, JJ; Hunt, SC; Ragni, MV | 1 |
| Brudnoy, D | 1 |
| Smith, L | 1 |
| Del Villar, A; González-López, A; Pozo, T; Velasco, E | 1 |
| Arvieux, C; Bazin, C; Bellissant, E; Cartier, F; Chauvin, JP; Delfraissy, JF; Dohin, E; Michelet, C; Raffi, F; Renard, I; Ruffault, A; Sébille, V | 1 |
| Hirsch, M; Hirschel, B; Lange, J; Leavitt, R; Meibohm, A; Mellors, J; Rawlins, S; Scerpella, E; Squires, K; Staszewski, S; Steigbigel, R | 1 |
| Ahmad, M; Brennan, JM; Caliendo, AM; Fiske, WD; Flanigan, TP; Gormley, JM; Tashima, KT | 1 |
| Bonhoeffer, S; Hellmann, N; Ho, DD; Lie, YS; Markowitz, M; Parkin, NT; Petropoulos, CJ | 1 |
| Kang-Birken, SL; Prichard, JG | 1 |
| Danner, SA; Foudraine, NA; Goudsmit, J; Hamann, D; Kauffmann, RH; Meenhorst, PL; Miedema, F; Notermans, DW; Pakker, NG; Roos, MT; Schellekens, PT | 1 |
| Feingold, KR; Grunfeld, C; Khovidhunkit, W; Memon, RA; Mulligan, K; Pang, M; Schambelan, M; Shigenaga, JK | 1 |
| Staszewski, S | 1 |
| Fujimatsu, Y; Fukahori, S; Honda, J; Jojima, H; Oizumi, K; Okubo, Y; Shiraishi, K; Tanaka, K; Tanaka, M | 1 |
| Clotet, B; Gómez-Cano, M; Leal, M; Pérez-Olmeda, M; Puig, T; Rey, C; Rubio, A; Ruiz, L; Soriano, V; Xaus, N; Zamora, L | 1 |
| Dawson, D; DeMasi, R; Hill, AM; Opravil, M | 1 |
| Connick, E; Evans, TG; Fox, L; Heath-Chiozzi, M; Kessler, H; Kuritzkes, DR; Landay, A; Lederman, HM; Lederman, MB; Lederman, MM; Roe, J; Smith, KY; Spritzler, J; Valdez, H | 1 |
| Hart, AA; Hoetelmans, RM; Lange, JM; Mulder, JW; Reijers, MH; Reiss, P; Schuitemaker, H; Ten Kate, RW; Weigel, HM; Weverling, GJ | 1 |
| Beguinot, I; Bernard, P; Derancourt, C; Drobacheff, C; Verraes, S | 1 |
| Zorrilla, CD | 1 |
| Avilés, A; Halabe, J | 1 |
| Machuca, A; Soriano, V | 1 |
| Dechant, C; Goldwich, A; Grunke, M; Harrer, T; Kalden, JR; Kasten, S; Rascu, A; Schmitt, M | 1 |
| Acosta, EP; Bassett, RL; Bell, D; Eron, JJ; Fife, K; Johnson, VA; Kuritzkes, DR; Marschner, IC; Martinez, A; Murphy, RL; Pettinelli, CB; Sommadossi, JP; Wood, K | 1 |
| Behrens, GM; Meyer, D; Schmidt, RE; Stoll, M | 1 |
| Neto, JL; Siciliano, RF | 1 |
| Chiodo, F; Fiacchi, P; Manfredi, R; Riolo, U | 1 |
| Kuritzkes, DR; Landay, AL; Lederman, MM; Mosier, DE; Picchio, GR; Sabbe, R; Valdez, H | 1 |
| Church, JA; Cutrell, A; Emmanuel, P; Hetherington, S; Mitchell, C; Nelson, RP; Richardson, CG; Sáez-Llorens, X; Sleasman, J; Spreen, W; Van Dyke, R; Wiznia, A | 1 |
| Kerr, C | 1 |
| Airoldi, M; Carosi, G; Castelli, F; Patroni, A; Quiros-Roldan, E; Signorini, S; Torti, C | 1 |
| Farinotti, R; Firtion, G; Mandelbrot, L; Peytavin, G | 1 |
| Albuzza, M; Amorico, G; Bedini, A; Esposito, R; Guaraldi, G; Orlando, G; Ventura, P | 1 |
| Iwata, M; Ota, K; Shimizu, Y; Takeuchi, M; Yogo, Y | 1 |
| Bartley, PB; Boots, RJ; Hyland, VJ; Lawson, M; Potter, JM; Westacott, L; Woods, ML | 1 |
| Angelosante, W; Carneiro, M; Maneiro, P; Pérez, C; Sanchéz, A; Valleé, M | 1 |
| Caldwell, P; Furlan, S; Ho, D; Hurley, A; Johnson, J; Kost, RG; Markowitz, M; Smiley, L; Talal, A; Vesanen, M; Zhang, L | 1 |
| Bulgheroni, E; Citterio, P; d'Arminio-Monforte, A; De Pasquale, MP; Galli, M; Milazzo, L; Moroni, M; Moscatelli, G; Rusconi, S | 1 |
| Anderson, KS; Feng, JY; Johnson, AA; Johnson, KA | 1 |
| Laurence, J | 1 |
| Mascolini, M | 1 |
| Poscher, M | 1 |
| Levin, J | 1 |
| Baker, R | 2 |
| Gilden, D | 1 |
| Smart, T | 1 |
| Coombs, R; Cotton, D; Hammer, S; Saag, M; van der Horst, C | 1 |
| James, JS | 2 |
| Alcorn, K | 1 |
| Torres, G | 1 |
| Marks, S | 1 |
| Cadman, JA | 1 |
| Zuger, A | 1 |
| Reiter, GS | 1 |
| Golk, M | 1 |
| Bulgheroni, E; Citterio, P; Croce, F; Galazzi, M; Galli, M; Kurtagic, S; La Seta Catamancio, S; Moroni, M; Rusconi, S | 1 |
| Burger, DM; de Wolf, F; Foudraine, NA; Hoetelmans, RM; Jurriaans, S; Lange, JM; Maas, J; Miedema, F; Portegies, P; Reiss, P; Roos, MT; Weverling, GJ | 1 |
| Chougnet, C; Fowke, K; Jankelevich, S; Liewehr, D; Mueller, BU; Pizzo, PA; Shearer, GM; Steinberg, SM; Yarchoan, R | 1 |
| Haase, CP; Hoit, BD; Lewis, W; Raidel, SM; Russ, RB; Samarel, AM; Sutliff, RL | 1 |
| Agut, H; Bonmarchand, M; Brun-Vezinet, F; Calvez, V; Costagliola, D; Coutellier, A; Delaugerre, C; Descamps, D; Izopet, J; Katlama, C; Massip, P; Matheron, S; Mouroux, M; Valantin, MA; Yvon, A | 1 |
| Angarano, G; Arici, C; Balotta, C; Bertoli, A; Cozzi-Lepri, A; Facchi, G; Forbici, F; Ippolito, G; Monforte, AD; Moroni, M; Narciso, P; Orani, A; Perno, CF; Pezzotti, P; Poggio, A; Raise, E; Scalzini, A; Violin, M | 1 |
| Bachmeyer, C; Benchaa, B; Blum, L; Danne, O; Gruat, N; Stelianides, S | 1 |
| Johnson, GM; Krogstad, PA; Lee, S; Mohan, K; Morse, EV; Nachman, S; Stanley, K; Van Dyke, RB; Wiznia, A | 1 |
| Bean, P | 1 |
| Battegay, M; Bernasconi, E; Bisset, LR; Chave, JP; Fischer, M; Furrer, H; Günthard, H; Hirschel, B; Howe, C; Lazzarin, A; Ledergerber, B; Opravil, M; Perrin, L; Vernazza, P; Weber, R; Yerly, S | 1 |
| Ait-Khaled, M; Clumeck, N; Cutrell, A; Fischl, MA; Gould, J; Greenberg, SB; Griffin, P; Lafon, S; Pearce, G; Peters, BS; Pulido, F; Rakik, A; Rubio, R; Spreen, W; Tisdale, M | 1 |
| Boehme, RE; Cameron, JM; Cammack, N; Coates, JA; Marr, CL; Penn, CR; Reid, PJ; Rouse, P | 1 |
| Gao, Q; Li, XG; Parniak, MA; Rooke, R; Soudeyns, H; Tremblay, M; Wainberg, MA; Yao, XJ | 1 |
16 review(s) available for lamivudine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Combinations; HIV Infections; Humans; Lamivudine; Nelfinavir; Oligopeptides; Pyridines; Randomized Controlled Trials as Topic; Zidovudine | 2013 |
A combination drug of abacavir-lamivudine-zidovudine (Trizivir) for treating HIV infection and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Drug Combinations; HIV Infections; Humans; Lamivudine; Nelfinavir; Oligopeptides; Pyridines; Randomized Controlled Trials as Topic; Zidovudine | 2009 |
[Complete auriculoventricular block in a patient treatment with Lopinavir/Ritonavir].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Aryl Hydrocarbon Hydroxylases; Bundle-Branch Block; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Inhibitors; Heart; Heart Block; HIV Protease Inhibitors; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Oxidoreductases, N-Demethylating; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Syncope; Zidovudine | 2002 |
Cutaneous EBV-related lymphoproliferative disorder in a 15-year-old boy with AIDS: an unusual clinical presentation.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Antigens, CD; Antiretroviral Therapy, Highly Active; Combined Modality Therapy; Diagnosis, Differential; Epstein-Barr Virus Infections; Gene Rearrangement, T-Lymphocyte; Herpesvirus 4, Human; HIV Protease Inhibitors; Humans; Immunophenotyping; Indinavir; Lamivudine; Lymphoma, AIDS-Related; Lymphoma, T-Cell, Cutaneous; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Sarcoma, Kaposi; Skin Neoplasms; Stavudine; Transfusion Reaction; Viral Matrix Proteins | 2002 |
Where now for Trizivir? Role of the triple-NRTI pill post-ACTG 5095.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Chemistry, Pharmaceutical; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Humans; Lamivudine; Patient Selection; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Zidovudine | 2003 |
Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Reverse Transcriptase Inhibitors; Tenofovir | 2003 |
The impact of abacavir on lipids and lipodystrophy.
Topics: Acquired Immunodeficiency Syndrome; Cross-Sectional Studies; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; HIV Infections; Humans; Hyperlipidemias; Incidence; Lamivudine; Lipodystrophy; Male; Randomized Controlled Trials as Topic; Risk Assessment | 2005 |
Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; DNA Replication; DNA, Mitochondrial; Humans; Lamivudine; Mitochondria; Nucleosides; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2005 |
Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Nevirapine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Stavudine | 2006 |
Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Treatment Outcome; Zidovudine | 2007 |
Antiretroviral therapy: a guide to the most important trials.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; Humans; Indinavir; Lamivudine; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Viral Load; Zalcitabine; Zidovudine | 1997 |
[Antiretroviral treatment and resistance].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Drug Resistance, Microbial; HIV-1; Humans; Lamivudine; Mutation; Mycobacterium tuberculosis; Retroviridae Infections; Reverse Transcriptase Inhibitors; Zidovudine | 1997 |
HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Lamivudine; Pityriasis Rubra Pilaris; Saquinavir; Zidovudine | 1999 |
[Early treatment of sexual exposure to human immunodeficiency virus].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Combinations; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Nelfinavir; Probability; Risk Factors; Sexual Behavior; Sexual Partners; Time Factors; Zidovudine | 2000 |
Mother-to-child HIV-1 transmission: state of the art and implications for public policy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Cesarean Section; Clinical Trials as Topic; Female; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Monitoring, Physiologic; Pregnancy; Pregnancy Complications, Infectious; Public Policy; Registries; Reverse Transcriptase Inhibitors; Risk Factors; RNA, Viral; Viral Load; Zidovudine | 2000 |
The multiple benefits associated with HIV drug-resistance mutation M184V.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Resistance, Viral; HIV-1; Humans; Lamivudine; Mutation | 2002 |
53 trial(s) available for lamivudine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Development of Dolutegravir Single-entity and Fixed-dose Combination Formulations for Children.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Aged; Anti-HIV Agents; Biological Availability; Dideoxynucleosides; Drug Combinations; Heterocyclic Compounds, 3-Ring; Humans; Lamivudine; Middle Aged; Oxazines; Piperazines; Pyridones; Tablets; Young Adult | 2022 |
[Effectiveness and safety of generic version of lamivudine/tenofovir and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2012-2014].
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Analysis of Variance; Anti-HIV Agents; Benzoxazines; Colombia; Cyclopropanes; Drugs, Generic; Female; Humans; Lamivudine; Male; Prospective Studies; Reproducibility of Results; Statistics, Nonparametric; Tenofovir; Time Factors; Treatment Outcome; Young Adult | 2019 |
Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; CD4 Lymphocyte Count; Female; Hospitals, Teaching; Hospitals, University; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Nigeria; Stavudine; Treatment Outcome | 2008 |
[The clinical and biological tolerance of nevirapine among patients with AIDS under treatment at the Hospital of the Point G].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Stavudine; Treatment Outcome | 2007 |
A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Ritonavir; RNA, Viral; South Africa; Stavudine; Treatment Outcome; Zidovudine | 2010 |
Open-label randomized multicenter selection study of once daily antiretroviral treatment regimen comparing ritonavir-boosted atazanavir to efavirenz with fixed-dose abacavir and lamivudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alanine Transaminase; Alkynes; Anti-Retroviral Agents; Atazanavir Sulfate; Benzoxazines; Bilirubin; Cholesterol; Cyclopropanes; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; HIV Infections; Humans; Japan; Lamivudine; Oligopeptides; Pyridines; Ritonavir; Treatment Outcome | 2011 |
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Black or African American; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Nitriles; Organophosphonates; Pyrimidines; Rilpivirine; Sex Factors; Tenofovir; Treatment Outcome; Viral Load; Zidovudine | 2012 |
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Biomarkers; C-Reactive Protein; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Female; HIV-1; Humans; Inflammation; Interleukin-6; Lamivudine; Male; Oligopeptides; Organophosphonates; Pyridines; Ritonavir; Tenofovir; Tumor Necrosis Factor-alpha | 2012 |
Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Atrophy; CD4 Lymphocyte Count; DNA, Mitochondrial; Drug Combinations; Drug Therapy, Combination; HIV Seropositivity; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Subcutaneous Fat; Treatment Outcome; Young Adult; Zidovudine | 2012 |
A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298).
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamivudine; Male; Middle Aged; RNA, Viral; Stavudine; Zidovudine | 2002 |
A randomized, open-label, comparative trial of BID and TID dosing of saquinavir enhanced oral formulation as part of a triple therapy for advanced AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Female; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Zidovudine | 2002 |
Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Child; Dideoxynucleosides; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV-1; Humans; Lamivudine; Nelfinavir; Phenotype; RNA, Viral; Zidovudine | 2002 |
Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudine.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Drug Resistance, Viral; HIV Protease; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Mutation; RNA, Viral; Zidovudine | 2004 |
Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Retroviral Agents; Cytidine Triphosphate; Deoxycytosine Nucleotides; Deoxyguanine Nucleotides; Dideoxynucleotides; Drug Interactions; HIV-1; Humans; Lamivudine; Male; Metabolic Clearance Rate; Middle Aged; Mycophenolic Acid | 2004 |
HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Indinavir; Lamivudine; Male; Nelfinavir; Phenotype; Stavudine; Treatment Failure; Zidovudine | 2004 |
Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complex.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Complex; Base Sequence; DNA Primers; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Lamivudine; Male; Molecular Sequence Data; Mutation; Phenotype; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Zalcitabine | 1995 |
A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; beta 2-Microglobulin; Female; HIV Core Protein p24; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Time Factors; Zalcitabine | 1995 |
Hair loss associated with lamivudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alopecia; Antiviral Agents; Female; Humans; Lamivudine; Male; Middle Aged; Zalcitabine | 1994 |
Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Antiviral Agents; Female; Half-Life; Humans; Kidney Diseases; Lamivudine; Male; Metabolic Clearance Rate; Middle Aged | 1996 |
Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4-CD8 Ratio; Didanosine; DNA, Viral; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocytes; Male; Pilot Projects; Proviruses; RNA, Viral; Zidovudine | 1997 |
Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial.
Topics: Acetamides; Acetophenones; Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Health Services; HIV-1; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1997 |
Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Cytomegalovirus Retinitis; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Prospective Studies; Saquinavir; Zidovudine | 1997 |
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Zidovudine | 1997 |
Stavudine, lamivudine and indinavir in children with advanced HIV-1 infection: preliminary experience.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Indinavir; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pilot Projects; Retrospective Studies; Stavudine; Zidovudine | 1997 |
The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell count.
Topics: Acetamides; Acetophenones; Acquired Immunodeficiency Syndrome; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; RNA, Viral; Treatment Outcome; Viral Load; Zalcitabine; Zidovudine | 1998 |
A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cohort Studies; Dideoxynucleosides; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; HIV-1; Humans; Lamivudine; RNA, Viral; Time Factors; Viral Load; Zidovudine | 1998 |
Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antigens, Bacterial; CD4-Positive T-Lymphocytes; Cell Division; Chemokines; Cytokines; Double-Blind Method; Female; HIV Antigens; HIV-1; Humans; Indinavir; Lamivudine; Male; Mitogens; RNA, Viral; Viremia; Zidovudine | 1999 |
The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Drug Therapy, Combination; HIV-1; Homosexuality, Male; Humans; Lamivudine; Male; Middle Aged; Pilot Projects; Ritonavir; RNA, Viral; T-Lymphocytes, Cytotoxic; Time Factors; Viremia; Virus Replication; Zidovudine | 1999 |
Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Genotype; HIV Protease Inhibitors; Humans; Lamivudine; Male; Middle Aged; Mutation; Pilot Projects; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Severity of Illness Index; Time Factors; Viral Load; Zidovudine | 1999 |
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Male; Survival Rate; Zidovudine | 1999 |
Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Indinavir; Lamivudine; Oxazines; Viral Load; Zidovudine | 1999 |
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Follow-Up Studies; HIV-1; Humans; Immunologic Memory; Lamivudine; Lymphocyte Count; Lymphocytes; Reference Values; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; T-Lymphocytes; Time Factors; Viral Load; Zidovudine | 1999 |
Update on study 006--EFV + AZT + 3TC versus the current 'standard of care' IDV + AZT + 3TC.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Humans; Indinavir; Lamivudine; Lipid Metabolism; Oxazines; Viral Load; Zidovudine | 1999 |
Prediction of HIV-1 RNA suppression and its durability during treatment with zidovudine/lamivudine.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; HIV-1; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; RNA, Viral; Zidovudine | 1998 |
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Therapy, Combination; Female; Hemocyanins; Hepatitis A Vaccines; HIV-1; Humans; Hypersensitivity, Delayed; Injections, Intradermal; Lamivudine; Male; Middle Aged; Ritonavir; T-Lymphocytes; Tetanus Toxoid; Thymus Gland; Vaccination; Viral Hepatitis Vaccines; Zidovudine | 2000 |
Toxicity and drug exposure in a quadruple drug regimen in HIV-1 infected patients participating in the ADAM study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Diarrhea; Drug Therapy, Combination; Female; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Liver; Male; Middle Aged; Nausea; Nelfinavir; Reverse Transcriptase Inhibitors; Saquinavir; Stavudine | 2000 |
Improved prognosis in patients with acquired immunodeficiency syndrome-related lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lymphoma, AIDS-Related; Male; Middle Aged; Mitoxantrone; Prognosis; Survival Rate; Vincristine; Zidovudine | 1999 |
Positive influence of the Delta32CCR5 allele on response to highly active antiretroviral therapy (HAART) in HIV-1 infected patients.
Topics: Acquired Immunodeficiency Syndrome; Alleles; Anti-HIV Agents; Cohort Studies; Dideoxynucleosides; Drug Resistance, Microbial; Female; HIV-1; Humans; Lamivudine; Male; Receptors, CCR5; Zidovudine | 2000 |
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Delavirdine; Female; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Reverse Transcriptase Inhibitors; Stavudine; Time Factors; Viral Load; Zidovudine | 2000 |
Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antigens, Viral; Base Sequence; CD4-Positive T-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Mice; Mice, SCID; Molecular Sequence Data; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Sequence Analysis, DNA; Viral Load; Zidovudine | 2000 |
A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Confidence Intervals; Dideoxynucleosides; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Growth; HIV-1; Humans; Infant; Lamivudine; Male; RNA, Viral; Zidovudine | 2001 |
Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1--infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; Chronic Disease; Dideoxynucleosides; Digestive System; Drug Synergism; Ethnicity; Female; Furans; HIV Infections; HIV-1; Humans; Lamivudine; Lymphocyte Subsets; Male; Pregnancy; Research Design; RNA, Viral; Sulfonamides; Treatment Refusal; Zidovudine | 2001 |
Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV-1; Humans; Lamivudine; Mutation; Phenotype; RNA, Viral; Zidovudine | 1997 |
Drug combination shows benefits for AIDS patients with history of taking AZT.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; HIV; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Zidovudine | 1996 |
Sustiva combination effective as initial treatment.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Indinavir; Lamivudine; Oxazines; Treatment Outcome | 1998 |
Merck protease inhibitor trial seeks persons with CD4 count under 50.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4 Lymphocyte Count; Drug Industry; Drug Therapy, Combination; HIV Protease Inhibitors; Hotlines; Humans; Indinavir; Lamivudine; Patient Selection; Pyridines; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine | 1995 |
New protease inhibitor studies.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Pyridines; Randomized Controlled Trials as Topic; Zalcitabine; Zidovudine | 1995 |
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4 Lymphocyte Count; Drug Therapy, Combination; Follow-Up Studies; HIV-1; Humans; Indinavir; Lamivudine; Middle Aged; Prospective Studies; RNA, Viral; Zidovudine | 2001 |
Long-term protease inhibitor-containing therapy results in limited improvement in T cell function but not restoration of interleukin-12 production in pediatric patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Antigens; HIV Protease Inhibitors; Humans; Indinavir; Interleukin-12; Lamivudine; Male; Phytohemagglutinins; T-Lymphocytes; Time Factors; Treatment Outcome; Viral Load; Zidovudine | 2001 |
Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Child, Preschool; Drug Administration Schedule; Humans; Lamivudine; Nelfinavir; Nevirapine; Patient Compliance; Ritonavir; RNA, Viral; Stavudine; Treatment Outcome; Viral Load | 2002 |
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV-1; Humans; Lamivudine; Lipids; Male; Prospective Studies; RNA, Viral; Treatment Failure; Viral Load; Zidovudine | 2002 |
Observations of HIV-1 genotypic drug resistance in a trial of four reverse transcriptase inhibitors (Quattro Trial).
Topics: Acetamides; Acetophenones; Acquired Immunodeficiency Syndrome; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Viral Load; Zalcitabine; Zidovudine | 2002 |
Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Genotype; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Mutation; Phenotype; Zidovudine | 2002 |
147 other study(ies) available for lamivudine and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amniotic Fluid; Anti-HIV Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Fetal Blood; Genitalia, Female; HIV-1; Humans; Hydrocortisone; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral | 2009 |
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Child; COVID-19 Drug Treatment; Female; HIV Infections; Humans; Lamivudine; Lipopeptides | 2022 |
Serum Interleukin-6 and Weight Loss in Antiretroviral-naïve and Antiretroviral-treated Patients with HIV/AIDS: Relationships and Predictors.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Emtricitabine; HIV Infections; Humans; Interleukin-6; Lamivudine; Middle Aged; Nevirapine; Tenofovir; Weight Loss; Zidovudine | 2022 |
Risk factors and prognostic significance of platelet count abnormalities in children with HIV infection on antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Case-Control Studies; CD4 Lymphocyte Count; Child; HIV Infections; Humans; Lamivudine; Nevirapine; Platelet Count; Prognosis; Retrospective Studies; Risk Factors; Thrombocytopenia; Thrombocytosis | 2023 |
Doravirine/lamivudine/tenofovir disoproxil fumarate-induced hypertriglyceridemia in a newly diagnosed AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Emtricitabine; Fumarates; HIV Infections; Humans; Hypertriglyceridemia; Lamivudine; Tenofovir | 2022 |
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Retroviral Agents; Child; COVID-19; Hepatitis C; HIV Infections; Humans; Lamivudine; Practice Guidelines as Topic; Tenofovir | 2023 |
Tolerability and effectiveness of albuvirtide combined with dolutegravir for hospitalized people living with HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lamivudine; Middle Aged; Peptides; Pyridones; Retrospective Studies; Viral Load | 2023 |
Pediatric Kaposi's sarcoma associated with immune reconstitution inflammatory syndrome.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Child; Dideoxynucleosides; Drug Therapy, Combination; Female; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Lopinavir; Ritonavir; Sarcoma, Kaposi | 2020 |
Traditional Chinese Medicine Can Improve the Immune Reconstruction of HIV/AIDS Patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Drugs, Chinese Herbal; HIV Infections; Humans; Immune Reconstitution; Lamivudine; Medicine, Chinese Traditional; Middle Aged; Pilot Projects; Prospective Studies; T-Lymphocytes; Tenofovir; Treatment Outcome; Young Adult | 2020 |
Prevalence and evaluation of risk factors of anti-retroviral therapy failure among human immunodeficiency virus/acquired immune deficiency syndrome patients in North India.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; HIV; HIV Infections; Humans; India; Lamivudine; Male; Prevalence; Risk Factors; Viral Load; Zidovudine | 2021 |
Concomitant AIDS cholangiopathy and Fanconi syndrome as complications of HIV in a single patient.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cholangitis; Fanconi Syndrome; Female; HIV Infections; Humans; Lamivudine; Middle Aged; Tenofovir; Zidovudine | 2017 |
AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Coinfection; Drug Therapy, Combination; Female; Herpesvirus 8, Human; HIV-1; Hospitals, University; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Multivariate Analysis; Nevirapine; Proportional Hazards Models; Retrospective Studies; Sarcoma, Kaposi; Stavudine; Treatment Outcome; Urban Population; Zimbabwe | 2013 |
Hepatitis B prevalence and influence on HIV treatment outcome and mortality in the Chilean AIDS Cohort.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Chile; Coinfection; Cyclopropanes; Female; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Prevalence; Proportional Hazards Models; Retrospective Studies; Treatment Outcome | 2013 |
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Case-Control Studies; Drug Combinations; Drug Therapy, Combination; Genome-Wide Association Study; Genotype; Humans; Lamivudine; Multicenter Studies as Topic; Peripheral Nervous System Diseases; Polymorphism, Genetic; Principal Component Analysis; Randomized Controlled Trials as Topic; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2014 |
Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa.
Topics: Acquired Immunodeficiency Syndrome; Adult; Africa; Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Monitoring; Drug Resistance, Viral; Female; HIV-1; Hospitals, Rural; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Rural Health Services; Rural Population; Stavudine; Treatment Outcome; Zidovudine | 2014 |
MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Drug Resistance, Viral; Female; Gene Expression Regulation; HIV; Humans; Lamivudine; Leukocytes, Mononuclear; Male; MicroRNAs; Nevirapine; Stavudine; Treatment Outcome; Viral Load; Zidovudine | 2014 |
Pure red cell aplasia induced by lamivudine without the influence of zidovudine in a patient infected with human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Biopsy, Needle; Bone Marrow; Diagnosis, Differential; HIV Infections; Humans; Lamivudine; Male; Platelet Count; Red-Cell Aplasia, Pure; Young Adult; Zidovudine | 2014 |
[Analysis on HIV suppression effect after initiating antiretroviral treatment and related factors among AIDS patients in Henan province during 2008 and 2013].
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; Health Facilities; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Stavudine; Time-to-Treatment; Treatment Outcome; Zidovudine | 2015 |
Chronic action of lamivudine and ritonavir on maternal and fetal liver and kidney of albino pregnant rats (Rattus norvegicus albinus, Rodentia, Mammalia): morphological and biochemical aspects.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-Retroviral Agents; Drug Evaluation, Preclinical; Female; Kidney; Lamivudine; Liver; Pregnancy; Pregnancy Complications, Infectious; Rats; Rats, Wistar; Ritonavir | 2015 |
CD4 count improvement following tenofovir to abacavir switch in a patient with persistent lymphopenia despite an undetectable viral load.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; CD4 Lymphocyte Count; Deoxycytidine; Dideoxynucleosides; Emtricitabine; Female; Humans; Lamivudine; Middle Aged; Organophosphonates; Tenofovir | 2008 |
FDA grants tentative approval for 75th generic antiretroviral drug.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Approval; Drugs, Generic; Humans; Lamivudine | 2009 |
Doxorubicin-induced hyperpigmentation.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Carbamates; Doxorubicin; Drug Combinations; Furans; Humans; Lamivudine; Lip Diseases; Male; Melanosis; Nails, Malformed; Organophosphates; Ritonavir; Sarcoma, Kaposi; Sulfonamides; Tongue Diseases; Zidovudine | 2008 |
The obstetric face and challenge of HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Developing Countries; Disease Progression; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Maternal Mortality; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination; World Health Organization; Zidovudine | 2009 |
[Tolerance study of a triple first-line antiretroviral combination zidovudine, lamivudine and efavirenz in Dakar, Senegal].
Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anemia; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Drug Tolerance; HIV-1; Humans; Lamivudine; Senegal; Zidovudine | 2009 |
Adherence to antiretroviral drug therapy in children with HIV/AIDS in Jamaica.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Anti-Retroviral Agents; Biomarkers; CD4 Lymphocyte Count; Child; Child, Preschool; Cross-Sectional Studies; Female; HIV Infections; Humans; Infant; Jamaica; Lamivudine; Male; Medication Adherence; Nevirapine; Surveys and Questionnaires; Young Adult; Zidovudine | 2008 |
Central nervous system T-cell lymphoma in acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Brain; Central Nervous System Neoplasms; Humans; Lamivudine; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Pyrrolidinones; Raltegravir Potassium; Stavudine; Treatment Outcome | 2010 |
Specification of covariance structure in longitudinal data analysis for randomized clinical trials.
Topics: Acquired Immunodeficiency Syndrome; Bias; CD4 Lymphocyte Count; Computer Simulation; Humans; Indinavir; Lamivudine; Longitudinal Studies; Models, Statistical; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Zidovudine | 2010 |
Self-reported adherence to HAART in South-Eastern Nigeria is related to patients' use of pill box.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Algorithms; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Feasibility Studies; Female; HIV; HIV Infections; Humans; Lamivudine; Linear Models; Male; Medication Adherence; Middle Aged; Nevirapine; Nigeria; Patient Satisfaction; Prospective Studies; Reminder Systems; Risk Factors; Self Report; Stavudine; Surveys and Questionnaires; Treatment Outcome | 2010 |
Battles with donors cloud Malawi's HIV prevention plan.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Charities; Cyclopropanes; Drug Costs; Drug Therapy, Combination; Female; Health Policy; HIV Seropositivity; Humans; Infectious Disease Transmission, Vertical; International Cooperation; Lamivudine; Malawi; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir | 2011 |
Gender difference in 2-year mortality and immunological response to ART in an HIV-infected Chinese population, 2006-2008.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asian People; CD4 Lymphocyte Count; China; Female; Follow-Up Studies; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Sex Factors; Survival Rate; Treatment Outcome; Young Adult | 2011 |
Drug safety evaluation profile of stavudine plus lamivudine for HIV-1/AIDS infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; Evidence-Based Medicine; HIV Infections; HIV-1; Humans; Lamivudine; Patient Safety; Reverse Transcriptase Inhibitors; Risk Assessment; Risk Factors; Stavudine; Treatment Outcome | 2012 |
Autochthonous disseminated dermal and visceral leishmaniasis in an AIDS patient, southern Thailand, caused by Leishmania siamensis.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Female; Genes, Protozoan; Humans; Lamivudine; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Nevirapine; Phylogeny; Stavudine; Thailand | 2012 |
Monitoring of HAART regime antiretrovirals in serum of acquired immunodeficiency syndrome patients by micellar liquid chromatography.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Chromatography, Liquid; Cyclopropanes; Drug Monitoring; Humans; Lamivudine; Organophosphonates; Stavudine; Tenofovir; Zidovudine | 2012 |
Adverse drug reactions to antiretroviral therapy in AIDS patients at a tertiary care hospital in India: A prospective observational study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Central Nervous System Diseases; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; India; Lamivudine; Male; Medication Adherence; Middle Aged; Nevirapine; Severity of Illness Index; Stavudine; Tertiary Care Centers | 2010 |
High prevalence of genotypic resistance to nucleoside reverse transcriptase inhibitors among therapy-naive individuals from the Warsaw cohort.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Cohort Studies; Drug Resistance, Viral; Genotype; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Zidovudine | 2002 |
Effect of co-formulated zidovudine, lamivudine and abacavir (Trizivir) on antiretroviral-naive patients presenting with advanced HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Female; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Viral Load; Zidovudine | 2003 |
FDA notifications. Product tampering labels Ziagen as Combivir.
Topics: Acquired Immunodeficiency Syndrome; Dideoxynucleosides; Drug Combinations; Drug Labeling; Humans; Lamivudine; United States; United States Food and Drug Administration; Zidovudine | 2002 |
Dioxolane guanosine 5'-triphosphate, an alternative substrate inhibitor of wild-type and mutant HIV-1 reverse transcriptase. Steady state and pre-steady state kinetic analyses.
Topics: Acquired Immunodeficiency Syndrome; Cytidine Triphosphate; Deoxycytidine Monophosphate; Deoxyguanine Nucleotides; Dideoxynucleotides; Dioxolanes; DNA, Viral; Drug Resistance, Viral; Guanosine; Guanosine Triphosphate; HIV Reverse Transcriptase; HIV-1; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Substrate Specificity; Thymidine Monophosphate; Thymine Nucleotides; Zidovudine | 2003 |
AIDS drug in halted trial less effective as monotherapy.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzoxazines; Clinical Trials as Topic; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Humans; Lamivudine; Oxazines; Viral Load; Zidovudine | 2003 |
AIDS foundation seeks withdrawal of approval for HIV drug combination.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Anti-HIV Agents; Clinical Trials as Topic; Dideoxynucleosides; Drug Approval; Drug Combinations; Foundations; Humans; Lamivudine; United States; United States Food and Drug Administration; Zidovudine | 2003 |
Rapidly progressive human herpesvirus 8-associated solid anaplastic lymphoma in a patient with AIDS--associated Kaposi sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Disease Progression; Doxorubicin; Epstein-Barr Virus Infections; Fatal Outcome; Gastrointestinal Neoplasms; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV-1; Humans; Lamivudine; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms, Second Primary; Prednisone; Ritonavir; Saquinavir; Sarcoma, Kaposi; Skin Neoplasms; Stavudine; Tumor Virus Infections; Vincristine | 2003 |
GSK and Boehringer agree to generic AIDS drugs deal.
Topics: Acquired Immunodeficiency Syndrome; Africa South of the Sahara; Anti-Retroviral Agents; Commerce; Drug Industry; Drugs, Generic; Humans; Lamivudine; Legislation, Drug; South Africa; Zidovudine | 2003 |
Conference report - antiretroviral therapy update from the 9th European AIDS Conference.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Age Factors; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Botswana; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Administration Schedule; Drug Combinations; HIV Infections; Humans; Lamivudine; Middle Aged; Pulse Therapy, Drug; Reverse Transcriptase Inhibitors; Salvage Therapy; Viral Load; Zidovudine | 2003 |
Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy in human immunodeficiency virus coinfected patients: performance of CLIP sequencing and line probe assay.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Nucleic Acid Hybridization; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Sequence Analysis, DNA | 2003 |
[Viral hepatitis B/C and HIV. Therapy of double infections].
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiviral Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Treatment Outcome | 2003 |
[Ensuring high adherence. Clever combination assures therapeutic success].
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Humans; Lamivudine; Oxazines; Patient Compliance; Randomized Controlled Trials as Topic; Treatment Outcome; Zidovudine | 2003 |
[Long-term tolerance. Preventing lipoatrophy].
Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Dideoxynucleosides; DNA, Mitochondrial; Drug Combinations; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Long-Term Care; Risk Factors; Stavudine; Zidovudine | 2003 |
WHO hopes 3-by-5 plan will reverse Africa's HIV/AIDS epidemic.
Topics: Acquired Immunodeficiency Syndrome; Adult; Africa; Anti-HIV Agents; Child; Developing Countries; Disease Outbreaks; Drug Combinations; Female; Foster Home Care; HIV Infections; Humans; Lamivudine; Male; Nevirapine; Reverse Transcriptase Inhibitors; Stavudine; United Nations; World Health Organization | 2004 |
HIV/AIDS in China. A new treatment campaign, but with limited weapons.
Topics: Academies and Institutes; Acquired Immunodeficiency Syndrome; Anti-HIV Agents; China; Drug Costs; Drug Resistance, Viral; Drug Therapy, Combination; Foundations; HIV; HIV Infections; Humans; Lamivudine; Patents as Topic | 2004 |
WHO pulls two generic AIDS drugs from approved list.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Approval; Drugs, Generic; Formularies as Topic; Humans; Lamivudine; Therapeutic Equivalency; World Health Organization; Zidovudine | 2004 |
FDA approves two combo brand-name AIDS drugs.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Deoxycytidine; Dideoxynucleosides; Drug Approval; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Humans; Lamivudine; Organophosphorus Compounds; United States; United States Food and Drug Administration | 2004 |
Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Controlled Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Zidovudine | 2004 |
Neurological complications in AIDS patients: the 1-year retrospective study in Chiang Mai University, Thailand.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cytomegalovirus Infections; Female; Humans; Lamivudine; Male; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Stavudine; Toxoplasmosis | 2004 |
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Brain; CD4 Lymphocyte Count; Cidofovir; Cytosine; Dideoxynucleosides; Encephalitis; False Negative Reactions; Fatal Outcome; Humans; Immunocompromised Host; Indinavir; JC Virus; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Organophosphonates; Substance Abuse, Intravenous; Time Factors; Virus Activation; Zidovudine | 2004 |
Two AIDS medicines back on WHO prequalification list.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Approval; Drugs, Generic; Humans; Lamivudine; Therapeutic Equivalency; World Health Organization; Zidovudine | 2004 |
HIV/AIDS following sexual assault in Jamaican children and adolescents: a case for HIV post-exposure prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Anti-HIV Agents; Chemoprevention; Child; Child Abuse, Sexual; Drug Therapy, Combination; Female; HIV Infections; Humans; Jamaica; Lamivudine; Male; Rape; Risk Factors; Zidovudine | 2004 |
AIDS treatment. A step toward cheaper anti-HIV therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Developing Countries; Drug Approval; Drug Combinations; Drug Therapy, Combination; Drugs, Generic; Humans; Lamivudine; Nevirapine; United States; United States Food and Drug Administration; World Health Organization; Zidovudine | 2005 |
Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cholesterol; Dideoxynucleosides; Drug Combinations; Erythrocyte Indices; Humans; Lamivudine; Organophosphonates; Patient Compliance; Salvage Therapy; Tenofovir; Viral Load; Viremia; Zidovudine | 2005 |
Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Cyclopropanes; Exanthema; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Nevirapine; Pancreatitis; Peripheral Nervous System Diseases; Proportional Hazards Models; Rural Health; Stavudine; Survival Analysis; Uganda | 2007 |
Thyrotoxic periodic paralysis in a Polynesian male following highly active antiretroviral therapy for HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Autoimmunity; Diarrhea; Drug Combinations; Genetic Predisposition to Disease; Graves Disease; Hawaii; Humans; Hypokalemic Periodic Paralysis; Iodine Radioisotopes; Lamivudine; Lopinavir; Male; Native Hawaiian or Other Pacific Islander; Polynesia; Pyrimidinones; Thyrotoxicosis; Zidovudine | 2007 |
Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Area Under Curve; CD4 Lymphocyte Count; Extracellular Fluid; HIV-1; Humans; Intracellular Fluid; Lamivudine; Male; RNA, Viral; Semen; Zidovudine | 2008 |
Confusion reigns over compassionate use of AIDS drug.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; France; Humans; Lamivudine; Zalcitabine | 1995 |
[AIDS therapy with reverse transcriptase inhibitors].
Topics: Acquired Immunodeficiency Syndrome; Didanosine; Drug Therapy, Combination; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Zalcitabine; Zidovudine | 1993 |
Fighting all the time.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; HIV-1; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Virus Replication; Zalcitabine; Zidovudine | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Exacerbation of peripheral neuropathy by lamivudine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Humans; Lamivudine; Male; Peripheral Nervous System Diseases; Zalcitabine | 1995 |
AIDS mood upbeat--for a change.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Therapy, Combination; Gene Products, nef; Herpesviridae; HIV; Humans; Lamivudine; nef Gene Products, Human Immunodeficiency Virus; Sarcoma, Kaposi; Simian Immunodeficiency Virus; Virus Replication; Zalcitabine; Zidovudine | 1995 |
Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Resistance; HIV Infections; HIV-1; Humans; Lamivudine; Zalcitabine | 1993 |
Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Brain; Cells, Cultured; DNA, Viral; Fetus; HIV Core Protein p24; HIV-1; Humans; Lamivudine; Macrophages; RNA, Messenger; Stereoisomerism; Time Factors; Virus Replication; Zalcitabine; Zidovudine | 1993 |
A new HIV/AIDS drug.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Lamivudine; Male; Zalcitabine; Zidovudine | 1996 |
Lamivudine as adjunct therapy in HIV.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Therapy, Combination; HIV Infections; Humans; Lamivudine; Zalcitabine; Zidovudine | 1996 |
HIV's Achilles' heel. Drugs and education are starting to slow the AIDS virus.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Therapy, Combination; Health Education; Humans; Indinavir; Lamivudine; Pyridines; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine | 1996 |
Anti-CD4 therapy for AIDS suggested by mathematical models.
Topics: Acquired Immunodeficiency Syndrome; Antigens, CD; Antiviral Agents; CD4 Antigens; CD4 Lymphocyte Count; HIV-1; Host-Parasite Interactions; Humans; Lamivudine; Models, Theoretical; Zalcitabine | 1996 |
Drug updates.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Ganciclovir; Humans; Lamivudine | 1996 |
[HIV: to administer protease inhibitors early].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Time Factors; Zalcitabine; Zidovudine | 1996 |
Investigators study morning-after AIDS treatment.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Coitus; Contraceptives, Postcoital; Female; Health Knowledge, Attitudes, Practice; HIV-1; Humans; Lamivudine; Zidovudine | 1997 |
Treatment options for human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Child; Didanosine; Drug Approval; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Lamivudine; Male; Saquinavir; Stavudine; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1996 |
Decline in deaths from AIDS due to new antiretrovirals.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; British Columbia; CD4 Lymphocyte Count; Drug Therapy, Combination; Humans; Indinavir; Lamivudine; Mortality; Saquinavir; Stavudine | 1997 |
Cure or control of HIV/AIDS?
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Models, Biological; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine | 1997 |
Postexposure chemoprophylaxis for occupational exposure to HIV in the dental office.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Chemoprevention; Child; Dental Auxiliaries; Dentists; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Occupational Diseases; Occupational Exposure; Practice Guidelines as Topic; Risk Factors; United States; United States Public Health Service; Universal Precautions; Zidovudine | 1997 |
[Rhabdomyolysis in antiretroviral therapy with Lamivudin].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Creatine Kinase; Humans; Lamivudine; Male; Myoglobin; Rhabdomyolysis | 1997 |
The good news about AIDS.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; Humans; Lamivudine; Models, Theoretical; Protease Inhibitors; Time Factors; Zidovudine | 1997 |
Sho-saiko-to, a traditional Kampo medicine, enhances the anti-HIV-1 activity of lamivudine (3TC) in vitro.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Synergism; Drug Therapy, Combination; Drugs, Chinese Herbal; Flavonoids; HIV Core Protein p24; HIV-1; Humans; Lamivudine; Monocytes; Virus Replication; Zidovudine | 1997 |
[Chronic HIV- and chronic HBV infection with hematuria and proteinuria].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Chronic Disease; Environmental Monitoring; Erythrocyte Count; Hazardous Substances; Hematuria; Hepatitis B; HIV-1; Humans; Lamivudine; Male; Occupational Exposure; Proteinuria; Zidovudine | 1998 |
Early intervention to block HIV.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; Humans; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Zidovudine | 1998 |
[Efficacy of lamivudine on the replication of hepatitis B virus in a patient with acquired immunodeficiency syndrome].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Hepatitis B virus; Humans; Lamivudine; Male; Virus Replication | 1997 |
Antiretroviral therapy and improving AIDS survival.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Survival Analysis | 1998 |
Immune reconstitution in HAART-treated children with AIDS. Highly Active Anti-Retroviral Therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Child; Disease Progression; Female; Follow-Up Studies; Humans; Immunity, Cellular; Immunologic Memory; Lamivudine; Lymphocyte Count; Nelfinavir; Stavudine; Viral Load | 1998 |
Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; DNA, Viral; Drug Administration Schedule; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Homosexuality, Male; Humans; Lamivudine; Male; Middle Aged; Recurrence; Virus Activation | 1998 |
Delayed occurrence of Graves' disease after immune restoration with HAART. Highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Female; Graves Disease; Humans; Immunity; Indinavir; Lamivudine; Male; Ritonavir; Stavudine | 1998 |
[HIV, hepatitis, influenza: new antiviral agents].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiviral Agents; Child; Clinical Trials as Topic; Dideoxynucleosides; Enzyme Inhibitors; Guanidines; Hepatitis B; Humans; Influenza, Human; Lamivudine; Neuraminidase; Pyrans; Reverse Transcriptase Inhibitors; Sialic Acids; Zanamivir | 1999 |
Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Hemophilia A; Hepatitis C; HIV Protease Inhibitors; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Stavudine; Viral Load | 1999 |
I have learned to hope.
Topics: Acquired Immunodeficiency Syndrome; Attitude to Death; Attitude to Health; Boston; Fear; HIV Protease Inhibitors; Humans; Lamivudine; Male; Middle Aged; Radio; Reverse Transcriptase Inhibitors; Survivors; Zidovudine | 1996 |
AIDS: the new drug war.
Topics: Acquired Immunodeficiency Syndrome; Black or African American; Dideoxynucleosides; Drug Combinations; Drug Industry; Humans; Investments; Lamivudine; Stavudine; United States; Zidovudine | 1998 |
Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cell Line; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV-1; Humans; Lamivudine; Microbial Sensitivity Tests; Nelfinavir; Phenotype; Salvage Therapy; Time Factors; Transfection; Treatment Failure; Zidovudine | 1999 |
Paronychia of the great toes associated with protease inhibitors.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Humans; Lamivudine; Nails; Paronychia; Protease Inhibitors; Retrospective Studies; Toes | 1999 |
Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acquired Immunodeficiency Syndrome; Acute-Phase Proteins; Adult; Anti-HIV Agents; Cytokines; Female; HIV Infections; Humans; Infections; Lamivudine; Lipids; Lipoproteins; Male; Middle Aged; Phospholipases A; Protease Inhibitors | 1999 |
[Fatal lactic acidosis in a patient with acquired immunodeficiency syndrome treated with stavudine, lamivudine and indinavir].
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; Fatal Outcome; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stavudine | 1999 |
Presence of genotypic resistance in nucleoside analogue-treated HIV-1-infected patients with undetectable viral load.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; Drug Resistance; Genes, pol; Genotype; HIV-1; Humans; Lamivudine; Point Mutation; RNA, Viral; Zalcitabine; Zidovudine | 1999 |
In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV-1; HTLV-I Infections; HTLV-II Infections; Human T-lymphotropic virus 1; Human T-lymphotropic virus 2; Humans; Lamivudine; Middle Aged; Proviruses; T-Lymphocytes; Viral Load; Zidovudine | 2000 |
Immune reconstitution syndromes in human immuno-deficiency virus infection following effective antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cytomegalovirus Retinitis; Female; Hepatitis C; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lamivudine; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Reverse Transcriptase Inhibitors; Zidovudine | 2000 |
Assessing efficacy by measuring CD(4) counts and quality of life of AIDS patients treated with ritonavir, AZT and 3TC.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Humans; Lamivudine; Male; Quality of Life; Ritonavir; Viral Load; Zidovudine | 2000 |
[Antiretroviral therapy in HIV infection. Effects of the introduction of new drugs on health care expenditures, 1994-1999].
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cohort Studies; Drug Costs; Drug Prescriptions; Health Expenditures; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Italy; Lamivudine; Retrospective Studies; Reverse Transcriptase Inhibitors | 2000 |
Trizivir on the market.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Humans; Lamivudine; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration; Zidovudine | 2001 |
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Resistance, Microbial; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Mutation; Nelfinavir; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Saquinavir; Treatment Failure; Zidovudine | 2001 |
Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amniotic Fluid; Anti-HIV Agents; Diffusion; Female; Fetal Blood; Humans; Kinetics; Lamivudine; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious | 2001 |
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Bone Diseases, Metabolic; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Middle Aged; Osteoporosis; Reverse Transcriptase Inhibitors; Rib Fractures; Spinal Fractures; Stavudine | 2001 |
[Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
Topics: Acquired Immunodeficiency Syndrome; Aged; Antiretroviral Therapy, Highly Active; Humans; Indinavir; JC Virus; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Male; Treatment Outcome; Zidovudine | 2000 |
Large hepatic mitochondrial DNA deletions associated with L-lactic acidosis and highly active antiretroviral therapy.
Topics: Acidosis, Lactic; Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; DNA, Mitochondrial; Humans; Lamivudine; Male; Middle Aged; Saquinavir; Sequence Deletion; Stavudine | 2001 |
Vertical HIV-1 transmission: prophylaxis and paediatric follow-up.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Anti-HIV Agents; Didanosine; Drug Therapy, Combination; Female; Follow-Up Studies; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Ritonavir; Viral Load; Zidovudine | 2001 |
Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cytidine Triphosphate; Deoxycytosine Nucleotides; Dideoxynucleotides; DNA; DNA Polymerase gamma; DNA Replication; DNA-Directed DNA Polymerase; DNA, Mitochondrial; Exodeoxyribonucleases; Humans; Kinetics; Lamivudine; Mitochondria; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; Zalcitabine | 2001 |
Research study of combination AIDS therapies underway.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Therapy, Combination; Humans; Lamivudine; Zidovudine | 1996 |
Undetectable HIV levels after triple therapy with indinavir.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; RNA, Viral; Viral Load; Zidovudine | 1997 |
ACTG 320 trial halted as three-drug arm proves superior.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; United States; Zidovudine | 1997 |
HAART therapy: dividing the epidemic?
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Zidovudine | 1997 |
First clinical data presented on FortovAse.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Chemistry, Pharmaceutical; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Lamivudine; Saquinavir; Zidovudine | 1997 |
Ritonavir pediatric study results reported.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Child; Child, Preschool; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Lamivudine; Ritonavir; Zidovudine | 1998 |
Twice daily dosing study of Viracept.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lamivudine; Nelfinavir; Stavudine | 1998 |
AIDS task force grapples with faster access to protease drugs.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Drug Approval; Drug Design; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Pyridines; Treatment Outcome; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1995 |
Combination treatment and single drugs: interview with Margaret Poscher, M.D. Interview by John S. James.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Approval; Drug Combinations; Drug Therapy, Combination; Health Services Accessibility; Humans; Insurance, Health; Lamivudine; Managed Care Programs; United States; Zalcitabine; Zidovudine | 1995 |
3TC: now available again up to CD4 of 300.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Drug Industry; Drug Therapy, Combination; Humans; Lamivudine; Patient Selection; United States; Zalcitabine; Zidovudine | 1995 |
Protease inhibitors and prevention of cross resistance.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Carbamates; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Lamivudine; Nelfinavir; Pyridines; Quinolines; Saquinavir; Sulfonamides; Zalcitabine; Zidovudine | 1995 |
Glaxo broadens access to 3TC.
Topics: Acquired Immunodeficiency Syndrome; CD4 Lymphocyte Count; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Zalcitabine | 1995 |
Roaches of inner space.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Lamivudine; Mutation; T-Lymphocytes, Cytotoxic; Virulence; Virus Replication; Zalcitabine; Zidovudine | 1995 |
FDA triple header. Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; CD4 Lymphocyte Count; Child; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Mutation; Quinolines; Salvage Therapy; Saquinavir; Stavudine; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1995 |
FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Drug Resistance, Microbial; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Quinolines; Saquinavir; Stavudine; United States; United States Food and Drug Administration; Zalcitabine | 1995 |
To treat or not to treat--approaches to antiretroviral therapy. Interview by Anthony J. Japour.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Didanosine; Drug Therapy, Combination; HIV; Humans; Lamivudine; Practice Patterns, Physicians'; RNA, Viral; Zalcitabine; Zidovudine | 1996 |
Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Lamivudine; Zalcitabine; Zidovudine | 1995 |
Potent new AIDS drugs underscore promise of combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Drug Approval; Drug Resistance; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; Humans; Isoquinolines; Lamivudine; Quinolines; Saquinavir; United States; United States Food and Drug Administration; Zalcitabine; Zidovudine | 1996 |
Protease inhibitors shine in triple combinations.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Pyridines; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine | 1996 |
Europe out of step with the US.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Didanosine; Drug Costs; Europe; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Quinolines; Ritonavir; Saquinavir; Thiazoles; United States; Valine; Zalcitabine; Zidovudine | 1996 |
Top AIDS researchers' strategy for antiretroviral treatment.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Patient Compliance; Practice Guidelines as Topic; RNA, Viral; Stavudine; Zalcitabine; Zidovudine | 1996 |
Outdated yet out-of-reach: AIDS society treatment guidelines at the International Conference.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Decision Making; Didanosine; Drug Therapy, Combination; HIV; HIV Infections; Humans; Lamivudine; Practice Guidelines as Topic; Zalcitabine; Zidovudine | 1996 |
3TC clinical benefit: more data presented.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Disease Progression; Drug Therapy, Combination; Humans; Lamivudine; Male; Multicenter Studies as Topic | 1996 |
The first billion-dollar AIDS drug?
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Costs; Humans; Lamivudine | 1996 |
Some relief from the epidemic.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Drug Costs; Drug Therapy, Combination; Female; Health Services Accessibility; HIV Infections; HIV Protease Inhibitors; Hospitalization; Humans; Lamivudine; Male; New York City; Population Surveillance; Prevalence; United States | 1997 |
Treating a survivor.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Counseling; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Mycobacterium avium-intracellulare Infection; Pneumonia, Pneumocystis; Reverse Transcriptase Inhibitors; Stavudine; Treatment Outcome; Zidovudine | 1997 |
3-drug therapy reduces deaths and new AIDS-related illnesses by 50%.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 1997 |
Hepatitis in an HIV-infected man.
Topics: Acquired Immunodeficiency Syndrome; Adult; Alcohol Drinking; Anti-HIV Agents; Drug Therapy, Combination; Humans; Lamivudine; Liver; Liver Function Tests; Male; Nevirapine; Stavudine | 1997 |
To AIDS and back with Norvir, D4T, 3TC and nutritional therapies. An interview with Michael Golk.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Dietary Fats; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Hypercholesterolemia; Killer Cells, Natural; Lamivudine; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Triglycerides | 1998 |
Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine.
Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine | 2001 |
Combined antiretroviral therapy causes cardiomyopathy and elevates plasma lactate in transgenic AIDS mice.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atrial Natriuretic Factor; Calcium-Transporting ATPases; Cardiomyopathies; Drug Therapy, Combination; Echocardiography; Gene Expression; HIV Protease Inhibitors; Indinavir; Lactic Acid; Lamivudine; Mice; Mice, Transgenic; Microscopy, Electron; Myocardium; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Zidovudine | 2001 |
Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Genotype; HIV Reverse Transcriptase; Humans; Lamivudine; Mutation; Stavudine; Viral Load; Zidovudine | 2001 |
Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; HIV Reverse Transcriptase; Humans; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors | 2001 |
Mycobacterium xenopi pulmonary infection in an HIV infected patient under highly active antiretroviral treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Female; Humans; Immunocompromised Host; Lamivudine; Lung Diseases; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 2002 |
Cellular metabolism of (-) enantiomeric 2'-deoxy-3'-thiacytidine.
Topics: Acquired Immunodeficiency Syndrome; Blood Platelets; Cells, Cultured; Humans; Lamivudine; Lymphocytes; Pentosyltransferases; Phosphorylation; Pyrimidine Phosphorylases; Stereoisomerism; Thymidine Phosphorylase; Zalcitabine; Zidovudine | 1992 |
Biological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects: susceptibility and resistance to other drugs.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytosine; Drug Resistance, Microbial; HIV-1; Humans; Lamivudine; Nucleosides; Viral Plaque Assay; Virus Replication; Zalcitabine; Zidovudine | 1991 |